Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire Offers Web-Based Information Access with Release of DecisionSite Architecture


With the launch of its new product, DecisionSite, Spotfire is taking a continued step toward web-based functionality, said Bill Ladd, director of bioinformatics.

“This is essentially a new generation product for us,” Ladd said.

Known primarily for its data visualization tools, Cambridge, Mass.-based Spotfire is offering DecisionSite as an analytic application for life sciences decision makers. It uses identifier logic to enable seamless linking between a company’s proprietary data and other data sources.

Describing it as an informatin browser, Ladd said that one of the primary enhancements the architecture provides is the capability for company IT departments to write their own data objects to link disparate data sources into the system.

This allows researchers to extract knowledge from data sources without needing to know the underlying schema of each database. In addition, IT staff can update the system from a central location when data sources change without touching individual desktop machines.

Spotfire will initially configure DecisionSite based on individual clients’ needs, but the server-side functionality permits companies to modify the architecture to keep up with changing data needs on the fly, Ladd said.

“As the data models change it’s much easier to upgrade the configuration of the application [using DecisionSite] to allow users to obtain access to the same infor- mation even though the under- lying data structure is changing,” said Ladd.

DecisionSite is offered on a subscription-based licensing scheme, with prices starting at $3,500 per user per year.

— BT

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.